MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (741)	10/8/2003 10:52:00 AM
From: Icebrg	Read Replies (1) of 2240

>>Still to come this year: - EGF fusion protein - anti-anginogenesis product - colon cancer product.>> With some help from Denmark the anti-anginogenesis mAb has been identified. OGS writes the following on their website: MDX-OGS-1 The MDX-OGS-1 programme, conducted in collaboration with Medarex, is the lead programme at OGS designed to develop a fully human anti-Heparanase 1 antibody. As part of this programme, Medarex UltiMAb human antibody development system has been employed to generate antibody lead candidates that have been screened and characterised using unique assays designed by OGS. MDX-OGS-1, the first antibody product that binds to and neutralises the Heparanase 1enzyme, is expected to enter clinical trials in 2003. ogs.com It should perhaps be mentioned that there are three parties involved in this development. Apart from MEDX and OGS there is also participation from Genmab. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next